Chargement en cours...
The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan
OBJECTIVES/HYPOTHESIS: Dupilumab, which blocks the shared receptor component for interleukin‐4 and interleukin‐13, reduced polyp size, sinus opacification, and symptom severity, and was well tolerated in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the SINUS‐52 study (NCT028984...
Enregistré dans:
| Publié dans: | Laryngoscope |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8247406/ https://ncbi.nlm.nih.gov/pubmed/33226139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.29230 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|